Robert J Bitterman, Chairman, Pres. & CEO at Phio Pharmaceuticals, bought PHIO on Sep 22, 2026
Data as of Oct 16
▲ BUY$2.1K2,000 shares at $1.03Robert J Bitterman Chairman, Pres. & CEOPHIO Phio Pharmaceuticals Corp.
- Traded
- Sep 22, 2026
- Disclosed
- Sep 23, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
PHIO since disclosure
−14.6%
Similar stocks (XLV) since disclosure
+4.7%
XLV — its sector index fund
Change in closing price from Sep 23, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.